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Abstract
Background: The primary mucinous adenocarcinoma of the bladder is an extremely rare urologic entity, which is
found in less than 2% of all urinary bladder tumours and is often presented as metastatic.
Case presentation: A 69-year old male patient was diagnosed with a primary mucinous adenocarcinoma of the
bladder after undergoing a transurethral resection of a bladder tumour and complete examination of the entire
gastrointestinal tract to rule out other primary cites. Immunohistochemistry confirmed the nature of the tumour.
The patient underwent a radical cystoprostatectomy with en block bilateral pelvic lymphadenectomy and urinary
diversion with a Bricker ileostomy.
Conclusion: The primary adenocarcinoma creates a diagnostic dilemma, since it cannot be easily differentiated by
the adenocarcinoma that originates from the colon and the prostate. We advocate the radical surgical
management, after exclusion of any primary malignant sites related to the gastrointestinal tract. The
immunohistochemistry has a leading role, assisting with the differential diagnosis.
Background
Urinary bladder cancer is the second most frequent
tumour of the genitourinary tract [1]. Adenocarcinomas
account for less than 2% of all bladder cancers [2]. One
of the most common forms of adenocarcinoma of the
bladder is the metastatic adenocarcinoma. The primary
sites for these tumours include the rectum, stomach,
endometrium, breast, prostate, and ovaries. We present
such a case, providing a meticulous review of the cur-
rent literature.
Case presentation
A 69-year old male patient was admitted having gross
painless hematuria for the last 2 months with no other
comorbidities, apart from benign prostatic hyperplasia
treated with a-blockers. Ultrasound of the kidneys, the
bladder and the prostate showed an exophytic lesion of
the bladder and dilatation of the left pelvicaliceal system.
Intravenous urography (IVU) showed a radiolucent filling
defect in the bladder and a non functioning left kidney
(Fig. 1a). The next diagnostic step was to perform a
cystoscopy, which confirmed the presence of a lesion,
occupying the trigone of the bladder and the left ureteral
orifice. The patient was subjected to a transurethral resec-
tion of the lesion. The histopathological assessment
revealed an infiltrative mucinous adenocarcinoma. Com-
puted tomography (CT) (Fig. 1b), colonoscopy and gastro-
scopy revealed no other primary malignant site. Based on
the pathology report, the patient underwent a radical
cystoprostatectomy with en block bilateral pelvic lympha-
denectomy and urinary diversion with a Bricker ileostomy.
Gross examination
The specimen of radical cystoprostatectomy included
the urinary bladder with pericystic fatty tissue and the
prostate gland. On section, a tumour was identified,
measuring in the greatest dimension 3 cm. The tumour
was localized in the posterior bladder wall and had an
exophytic growth pattern with solid (nodular) appear-
ance. It seemed to invade the wall of the bladder,
extending to the proximal urethral margin of the
prostate.
Histological and immunohistochemical features
The grossly described tumour is a primary mucinous
adenocarcinoma of the urinary bladder, which invades
the wall of the bladder, both lobes of the prostate gland
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urothelium with intestinal metaplasia. The carcinoma
includes glandular configurations, having one cell layer
of cuboidal or columnar epithelium with large, dark
nuclei, signet-ring cells (Fig. 2), nuclear atypia and sev-
eral mitoses (Fig. 2). The reactivity for PAS and PAS-
diastase establishes the presence of intracellular and
extracellular mucin (Fig. 3). The primary nature of ade-
nocarcinoma is confirmed by the immunoreactivity for
keratins 7 and 20 (Fig. 3).
Discussion
The majority of primary adenocarcinomas of the urinary
bladder (50-60%) arise at the bladder base and almost
all of the remaining are associated with urachal rem-
nants [3]. The male to female ratio of non-urachal neo-
plasms approaches 3 to 1, in contrast to almost 1 to 1
for urachal tumours. Most patients are middle-aged
(mean, approximately 62 years). Many experts suggest
that adenocarcinomas arise through a process of intest-
inal metaplasia stimulated by chronic irritation. Among
other factors associated with urothelial adenocarcinoma,
exstrophy and persistent urachal remnants are the most
common. Adenocarcinomas arising in areas of urachal
remnants differ clinically from those occurring at the
bladder base, but these neoplasms are similar in their
pathology and behavior.
Hematuria is the most common presenting sign, man-
ifested in about 90% of patients. Almost half of the
patients complain about dysuria, nocturia, frequency
and pain. Cystoscopically, bladder adenocarcinomas
ordinarily appear as single, nodular tumours that can
not be reliably distinguished from urothelial neoplasms.
Adenocarcinomas of the urinary bladder, regardless of
site, include the following histologic variations: 1) Ade-
nocarcinoma non otherwise specified, 2) Adenocarci-
noma of enteric type, 3) Adenocarcinoma with signet-
ring cells, 4) Mucinous adenocarcinoma, 5) Clear cell
adenocarcinoma, 6) Hepatoid adenocarcinoma, 7)
Mixed adenocarcinoma [4]. The usual malignant
tumour is a well-to-moderately differentiated adenocar-
cinoma, secreting variable amounts of mucin. The
tumour cells represent a combination of columnar and
goblet cells [5].
Figure 1 a, Intravenous urogram showing a radiolucent filling defect in the bladder and a non functioning left kidney and b,
computed tomography of the pelvis.
Figure 2 a, Pools of extracellular mucin containing glandular configurations, b, signet-ring cells.
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includes large lakes of extracellular mucin mixed with
collections of tumour cells. By definition, these muci-
nous foci should constitute at least half of the tumour
mass. In some cases, there is an admixture of extracellu-
lar and intracellular mucin; the latter is resulting in sig-
net ring configuration [6].
Regarding immunohistochemistry, adenocarcinoma of
the urinary bladder expresses CEA, CDX-2, MUC-1,
MUC-2 and MUC-3, same as colonic adenocarcinoma.
Cytokeratins 7 and 20 are positive, in contrast with
colonic adenocarcinoma that expresses cytokeratin 20
but not cytokeratin 7 [7].
The differential diagnosis includes metastatic colonic
adenocarcinoma, urothelial neoplasms with glandular
differentiation, intestinal metaplasia and nephrogenic
metaplasia. Metastatic adenocarcinoma is differentiated
using the immunophenotype (CK7 negative and CK 20
positive). Urothelial neoplasm with glandular differentia-
tion may contain intracellular and luminal mucins; how-
ever, mucins are not abundant. In addition, in this type
of carcinoma, signet-ring cells are not prominent and
the “glands” are surrounded by pseudostratified epithe-
lium. Intestinal metaplasia may infiltrate the lamina pro-
pria or even the bladder wall. Mucinous lakes are not
uncommon in these cases and their presence in a tissue
s a m p l ei sd i a g n o s t i co fa d e n o c a r c i n o m ao n l yw i t ht h e
presence of neoplastic cells. The cells of intestinal meta-
plasia lack nuclear anaplasia and rarely involve the mus-
cularis propria. Nodular areas of cystitis glandularis rich
in goblet cells should be considered benign, even if the
nodules extend into the lamina propria.
Prognosis varies with stage, with survival approaching
75-100% among patients whose tumours are confined to
the urinary bladder. Unfortunately, low-stage cancers
account for fewer than 30% of reported cases [8]. Patients
with urachal tumours tend to have a better short-term
survival rate than those with nonurachal cancers [9].
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Figure 3 a, Intracellular and extracellular mucin PAS-d positive, b, glandular configurations CK7 positive and c, signet-ring cells CK20
positive.
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